Inclusion Criteria:  Men and women of any ethnicity. Age Range - 16 - 65 Patient must be able to comply with treatment plan and laboratory tests  Exclusion Criteria:  Neoplastic cancer within 5 years prior to screening, except for cutaneous basal cell or squamous cell cancer resolved by excision No immune system issues or immunodeficiency disease No history of viral illness which could be reactivated by immune downregulation Presence of clinically significant acute or unstable cardiovascular and cerebrovascular (stroke) Diagnosis of a transient ischemic attack in the 6 months prior to screening Patients infected with hepatitis, C or HIV Patients with Body Mass Index (BMI) > 40 kg/m2 Presence of active infection Any other illness, psychiatric disorder, alcohol or chemical dependence that in the opinion of the investigator would render a patient unsuitable to participate in the study Unable or unwilling to provide required blood sample for testing As for the male-participants they are recommended to avoid fertilization for the first 6 months after the clinical trial. If the patient has previously used any products in a month prior to the start of the trial. Known sleep disorder ie. obstructive sleep apnea Presence of schizophrenia, bipolar disorder Concurrent use of cannabis